Pressmeddelanden, rapporter och bolagsmeddelande för Cessatech
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: Second Quarter Report Q2-2024
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: Cessatech extends its undrawn Loan Facility Agreement to DKK 10 million to support the forthcoming US launch of its lead program CT001
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: Key Cessatech priorities for the rest of the year
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: Grant of incentive warrants to Employees, CEO and the Board of Directors
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: Cessatech announces changes to the Board of Directors
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: Minutes of the Extraordinary General Meeting – 5 July 2024
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: Cessatech presents new data on paediatric pain relief at the PAGE conference in Rome favouring its lead candidate CT001
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: EXTRAORDINARY GENERAL MEETING
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: Cessatech announces superior simulated pain efficacy in children favouring its lead candidate CT001 relative to its active comparators.
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: Cessatech reports first patient dosed in final Safety Study 0202 of lead product candidate CT001